The Clinical Core of the Massachusetts ADRC is housed in the Memory Disorders Unit at the Massachusetts General Hospital. The goal of the Clinical Core is to examine, diagnosis and enroll into the ADRC Patient registry men and women from all racial and ethnic backgrounds with AD and related dementias, including frontotemporal dementia, dementia with Lewy bodies, and other parkinsonian syndromes including progressive supranuclear palsy and cortical basoganglionic degeneration, along with individuals with mild cognitive impairment who are at heightened risk to develop AD. Associated goals of the Center are to characterize the neurological, psychiatric and neuropsychological features of dementia in these patient groups and to refer these carefully evaluated patients to specific research projects funded within the ADRC, as well as to national and local research projects. To this historical mission, we have added two new components for genetics and neuroimaging. The Genetic subcore will consolidate separate elements of existing ADRC genetic programs, including the systematic collection of family history on all patients who attend the Clinical Core, genetic counseling, ascertainment of subjects for local and national genetic research projects and DNA banking and genetic analyses. The Neuroimaging subcore will standardize the collection of MR, SPECT and PET images from individuals who attend the Core, refine and apply to these images automated quantitative analytic programs developed at MGH, and facilitate collaboration with MGH investigators and other local and national ADC projects. The Clinical Core supports a wide range of research funded outside of the Clinical Core, including research projects linked to the ADRC (i.e., Project 3) as well as local and national collaborative research.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Specialized Center (P50)
Project #
5P50AG005134-22
Application #
7063246
Study Section
Special Emphasis Panel (ZAG1)
Project Start
Project End
Budget Start
2005-04-01
Budget End
2006-03-31
Support Year
22
Fiscal Year
2005
Total Cost
$312,490
Indirect Cost
Name
Massachusetts General Hospital
Department
Type
DUNS #
073130411
City
Boston
State
MA
Country
United States
Zip Code
02199
Wilmoth, Kristin; LoBue, Christian; Clem, Matthew A et al. (2018) Consistency of traumatic brain injury reporting in older adults with and without cognitive impairment. Clin Neuropsychol 32:524-529
Quiroz, Yakeel T; Sperling, Reisa A; Norton, Daniel J et al. (2018) Association Between Amyloid and Tau Accumulation in Young Adults With Autosomal Dominant Alzheimer Disease. JAMA Neurol 75:548-556
Ting, Simon Kang Seng; Foo, Heidi; Chia, Pei Shi et al. (2018) Dyslexic Characteristics of Chinese-Speaking Semantic Variant of Primary Progressive Aphasia. J Neuropsychiatry Clin Neurosci 30:31-37
Burke, Shanna L; Hu, Tianyan; Fava, Nicole M et al. (2018) Sex differences in the development of mild cognitive impairment and probable Alzheimer's disease as predicted by hippocampal volume or white matter hyperintensities. J Women Aging :1-25
Dujardin, Simon; Bégard, Séverine; Caillierez, Raphaëlle et al. (2018) Different tau species lead to heterogeneous tau pathology propagation and misfolding. Acta Neuropathol Commun 6:132
Wang, Qi; Guo, Lei; Thompson, Paul M et al. (2018) The Added Value of Diffusion-Weighted MRI-Derived Structural Connectome in Evaluating Mild Cognitive Impairment: A Multi-Cohort Validation1. J Alzheimers Dis 64:149-169
Wang, Tingyan; Qiu, Robin G; Yu, Ming (2018) Predictive Modeling of the Progression of Alzheimer's Disease with Recurrent Neural Networks. Sci Rep 8:9161
DeVos, Sarah L; Corjuc, Bianca T; Commins, Caitlin et al. (2018) Tau reduction in the presence of amyloid-? prevents tau pathology and neuronal death in vivo. Brain 141:2194-2212
Lee, Christopher M; Jacobs, Heidi I L; Marquié, Marta et al. (2018) 18F-Flortaucipir Binding in Choroid Plexus: Related to Race and Hippocampus Signal. J Alzheimers Dis 62:1691-1702
Eftekharzadeh, Bahareh; Daigle, J Gavin; Kapinos, Larisa E et al. (2018) Tau Protein Disrupts Nucleocytoplasmic Transport in Alzheimer's Disease. Neuron 99:925-940.e7

Showing the most recent 10 out of 966 publications